Abstract
Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
| Translated title of the contribution | Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases |
|---|---|
| Original language | English |
| Patent number | 特許第5167408號 |
| Publication status | Published - 1800 |
